Docket Number:11A-940825
Inventor:Andrew H.-J. Wang, Kai-Fa Huang
IP Status:Issued TWI307362, US 7,846,719B2
Abstract:
Glutaminyl cyclase is a catalyst responsible for protein N-terminal pyroglutamate formation. This enzyme is very useful in the commercially large-scale production of bioactive hormones and anticancer drugs which need the N-terminal pyroglutamate residue for their biological activities. In addition, human glutaminyl cyclase is a possible drug target for the treatment of several human disorders, such as Alzheimer’s disease.
Fields of Application:
Commercially, glutaminyl cyclase may facilitate the large-scale production of clinically useful hormones and anticancer drugs in cases of that the N-terminal pyroglutamate is required in the biological functions of these proteins.
Advantages when compared to the existing technologies:
- Our expression system has a relatively higher level of the recombinant human glutaminyl cyclase.
- We provide a convenient method for separation and purification of human glutaminyl cyclase from Escherichia coli cell lysates.
- In contrast to previous expression systems (yeast and insect cells), our system is in low cost, and our separation and purification procedures needs only a short period.
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you.
